Archive Newsletter

  1. 10.21.24 -- New State Regulations For IV Therapy Compounding: Are You Compliant? 10/21/2024
    10/21/24 Drug Delivery Leader Newsletter
  2. 10.14.24 -- Oral Small Molecule Targeting Of Cancer With Cantex' Stephen Marcus 10/14/2024
    10/14/24 Drug Delivery Leader Newsletter
  3. 10.10.24 -- Frankly Fran: 5 Keys To Supplier/Purchasing Controls – And Product Quality 10/10/2024
    10/10/24 Drug Delivery Leader Newsletter
  4. 10.07.24 -- Bacterial Endotoxin Testing, Part 2: Prerequisites And Reagent Preparation 10/7/2024
    10/07/24 Drug Delivery Leader Newsletter
  5. 10.04.24 -- Revolutionize Your Drug Delivery With Nanoformed APIs 10/4/2024

    10/04/24 Drug Delivery Leader Newsletter

  6. Best of September: Top 5 Insights In Drug Formulation and Delivery 10/2/2024
  7. 09.30.24 -- LNP-Delivered mRNA Via Inhalation With Ethris' Carsten Rudolph And Thomas Langenickel 9/30/2024
    09/30/24 Drug Delivery Leader Newsletter
  8. 09.25.24 -- How To Select The Right Medical Device CMO 9/25/2024

    09/25/24 Drug Delivery Leader Newsletter

  9. 09.23.24 -- Rare Disease Targeting And Novel Therapy Delivery With Kymanox' Evan Edwards 9/23/2024
    09/23/24 Drug Delivery Leader Newsletter
  10. 09.16.24 -- FDA Issues Draft Guidance On Use-Related Risk Analysis (URRA) 9/16/2024
    09/16/24 Drug Delivery Leader Newsletter